Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity
Related Articles
Insights into the co-evolution of epithelial cells and fibroblasts in the esophageal tumor microenvironment
Cancer-associated fibroblasts (CAFs) are recruited and rewired by cancer cells to become protumorigenic. The molecular mechanisms underlying this crosstalk in esophageal cancer are completely unknown.…
ChemoNETosis: A road to tumor therapeutic resistance
Neutrophil extracellular traps (NETs) limit infection by trapping microorganisms and have recently been shown to induce tumor metastasis. In this issue of Cancer Cell, Mousset…
Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma
Campbell et al. aggregate genomics and transcriptomics data across melanoma datasets, harmonizing molecular and clinical annotation across samples. Immune cell gene expression patterns and tumor mutational…
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
de Visser and Joyce review the complex interplay between the tumor and its microenvironment throughout cancer evolution and discuss the tumor cell-intrinsic, cell-extrinsic, and systemic…
Pre-cancer: From diagnosis to intervention opportunities
The multi-step process of carcinogenesis implies the existence of pre-malignant yet altered states that involve both the potentially carcinogenic cell as well as its surrounding microenvironment.…
BQ.1.1, XBB.1, and XBB.1.5 neutralization after bivalent mRNA COVID-19 booster in patients with cancer
Ehmsen et al. evaluate the neutralizing capacity to current SARS-CoV-2 variants in patients with cancer before and after receiving the BNT162b2 bivalent mRNA vaccine booster.…
Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance
Circulating tumor cells (CTCs) are regarded as “seeds” of tumor metastasis. By dissecting the interaction between CTCs and immunocytes at single-cell scale, Liu et al. propose…
Mutations in IFN-γ signaling genes sensitize tumors to immune checkpoint blockade
Song and Chow demonstrate that while tumor-intrinsic mutations in the IFN-γ signaling pathway confer immune resistance across in vitro co-culture systems, such alterations associate with enhanced…
Adoptive cell transfer immunotherapy for patients with solid epithelial cancers
Efforts to apply adoptive cell transfer (ACT) immunotherapy to patients with common epithelial cancers have been stimulated by the demonstration that the majority of these…